Probiotic Blend (Multi-Strain)

ProbioticblendModerate dose evidence

Also known as: multi-strain probiotic, probiotic blend, broad-spectrum probiotic, multispecies probiotic

Add to a formula

A generic placeholder for a multi-strain probiotic blend, typically combining several Lactobacillus and Bifidobacterium species and sometimes Streptococcus thermophilus or a Bacillus spore. Meta-analyses of probiotics in irritable bowel syndrome include many multi-strain products dosed between 10 and 50 billion CFU per day, though evidence for blends as a class is less specific than for individual strains. Use this row when the exact strain list will be finalized with the manufacturer; the CFU total, not the number of strains, drives raw-material weight. Replace it with individual strain rows once the formula is set.

Research summary

Combined strains are studied for complementary effects on gut transit, fermentation, and mucosal immunity.

Dosage

Daily amounts, of compound. CFU shown in billions.

Lowest studiedTypical rangeHighest studiedUpper limit
10–50 B CFU

Amounts are total billions of CFU across all strains (enter 25 for 25 billion). Raw-material weight assumes a 100 billion CFU/g blended concentrate (10 mg per billion CFU); manufacturers add a 20–50% CFU overage at fill so the label claim holds through shelf life, and the label should state whether CFU are guaranteed at manufacture or at expiry. Blends of vegetative strains should be capsule or powder only.

Standardization: Each strain designated with CFU contribution; total CFU per gram on CoA

Source material: freeze-dried culture

As supplied: Assumes 100 billion CFU/g blended concentrate (10 mg per billion CFU); adjust to the blend CoA.

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Heat- and moisture-sensitive vegetative cells; capsule or dry powder only unless the blend is built entirely from spore-formers.

Formulation notes

Separate from antibiotic dosing by at least two hours. Keep water activity low; hygroscopic co-ingredients shorten viability.

Sources

  1. NIH ODS — Probiotics Fact Sheet for Health ProfessionalsNIH ODS
  2. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. (Niu 2020)PubMed
  3. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. (Goodoory 2023)PubMed

Related ingredients